Organization | Skin Laser & Surgery Specialists

Skin Laser & Surgery Specialists Report issue

Academic/Hospital

Organization Overview

First Clinical Trial

2015

NCT03508856

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

Skin Laser & Surgery Specialists

Active Ingredients

Drugs in Other Trials (3)

abobotulinumtoxinA (Dysport) (1 trial)

brimonidine (alphagan) (1 trial)

ingenol mebutate (picato) (1 trial)

Indications

Overview

Highest Phase: Phase 0
# of Trials: 2
# of Trial APIs: 3